| NCT04440943 |
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT04440943 |
Recruiting |
Celldex Therapeutics |
2022-03-31 |
| NCT03370198 |
Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT03370198 |
Active, not recruiting |
Celyad Oncology SA |
2019-01-15 |
| NCT03338543 |
PENS or TENS for Pain in Liver Cancer |
https://ClinicalTrials.gov/show/NCT03338543 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2018-04-30 |
| NCT03326791 |
Aspirin in Colorectal Cancer Liver Metastases |
https://ClinicalTrials.gov/show/NCT03326791 |
Recruiting |
Oslo University Hospital |
2023-10-31 |
| NCT03310008 |
Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases |
https://ClinicalTrials.gov/show/NCT03310008 |
Active, not recruiting |
Celyad Oncology SA |
2021-05-31 |
| NCT03307811 |
Endoscopic Ultrasound Guided Liver Biopsy |
https://ClinicalTrials.gov/show/NCT03307811 |
Completed |
AdventHealth |
2018-06-19 |
| NCT03299036 |
Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy |
https://ClinicalTrials.gov/show/NCT03299036 |
Completed |
National Cheng-Kung University Hospital |
2018-10-16 |
| NCT03264716 |
Transarterial Chemoembolization by Hepasphere Microspheres for the Treatment of Unresectable Colorectal Liver Metastasis |
https://ClinicalTrials.gov/show/NCT03264716 |
Completed |
National Taiwan University Hospital |
2018-01-26 |
| NCT03259867 |
Combination of TATE and PD-1 Inhibitor in Liver Cancer |
https://ClinicalTrials.gov/show/NCT03259867 |
Active, not recruiting |
Teclison Ltd. |
2020-10-30 |
| NCT03239158 |
Bioinformation Therapy for Liver Cancer |
https://ClinicalTrials.gov/show/NCT03239158 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2018-09-02 |
| NCT03223818 |
The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese Patients |
https://ClinicalTrials.gov/show/NCT03223818 |
Recruiting |
Chinese University of Hong Kong |
2020-07-01 |
| NCT03223142 |
Standardization of Multi-modal Tumor Ablation Therapy System |
https://ClinicalTrials.gov/show/NCT03223142 |
Recruiting |
Shanghai Zhongshan Hospital |
2019-12-31 |
| NCT03213314 |
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies |
https://ClinicalTrials.gov/show/NCT03213314 |
Completed |
University of Edinburgh |
2019-03-31 |
| NCT03195699 |
Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers |
https://ClinicalTrials.gov/show/NCT03195699 |
Recruiting |
Tvardi Therapeutics, Incorporated |
2020-07-31 |
| NCT03183219 |
Safety and Efficiency of γδ T Cell Against Liver Cancer |
https://ClinicalTrials.gov/show/NCT03183219 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2018-01-15 |
| NCT03164382 |
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03164382 |
Recruiting |
Sun Yat-sen University |
2019-12-31 |
| NCT03159585 |
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors |
https://ClinicalTrials.gov/show/NCT03159585 |
Completed |
Zhujiang Hospital |
2019-06-04 |
| NCT03151213 |
Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver |
https://ClinicalTrials.gov/show/NCT03151213 |
Recruiting |
Tanta University |
2019-12-31 |
| NCT03146637 |
Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT03146637 |
Recruiting |
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. |
2020-12-31 |
| NCT03143270 |
A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT03143270 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-04-30 |
| NCT03143140 |
The Effect of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03143140 |
Active, not recruiting |
Beijing Cancer Hospital |
2018-03-31 |
| NCT03135652 |
Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation |
https://ClinicalTrials.gov/show/NCT03135652 |
Recruiting |
Wuhan Union Hospital, China |
2021-06-01 |
| NCT03132792 |
AFPᶜ³³²T in Advanced HCC |
https://ClinicalTrials.gov/show/NCT03132792 |
Recruiting |
Adaptimmune |
2021-06-30 |
| NCT03127072 |
Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM |
https://ClinicalTrials.gov/show/NCT03127072 |
Recruiting |
Fudan University |
2019-12-31 |
| NCT03109262 |
Yttrium Y 90 Glass Microspheres PET/CT in Imaging Patients With Liver Tumors |
https://ClinicalTrials.gov/show/NCT03109262 |
Active, not recruiting |
Stanford University |
2020-02-15 |
| NCT03101475 |
Synergism of Immunomodulation and Tumor Ablation |
https://ClinicalTrials.gov/show/NCT03101475 |
Recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2021-08-31 |
| NCT03092895 |
A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC |
https://ClinicalTrials.gov/show/NCT03092895 |
Recruiting |
Jiangsu HengRui Medicine Co., Ltd. |
2018-11-30 |
| NCT03088150 |
COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation |
https://ClinicalTrials.gov/show/NCT03088150 |
Recruiting |
VU University Medical Center |
2022-07-31 |
| NCT03053466 |
APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors |
https://ClinicalTrials.gov/show/NCT03053466 |
Active, not recruiting |
Apollomics (Australia) Pty. Ltd. |
2020-02-29 |
| NCT03037437 |
Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer |
https://ClinicalTrials.gov/show/NCT03037437 |
Recruiting |
The University of Texas Health Science Center at San Antonio |
2022-04-30 |
| NCT03028311 |
Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT03028311 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2021-01-31 |
| NCT02984566 |
Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM) |
https://ClinicalTrials.gov/show/NCT02984566 |
Recruiting |
University of Sydney |
2021-03-31 |
| NCT02954913 |
Simultaneous Resection of Colorectal Cancer With Synchronous Liver Metastases |
https://ClinicalTrials.gov/show/NCT02954913 |
Recruiting |
Hamilton Health Sciences Corporation |
2020-10-31 |
| NCT02947165 |
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. |
https://ClinicalTrials.gov/show/NCT02947165 |
Recruiting |
Novartis |
2021-04-13 |
| NCT02932956 |
Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) |
https://ClinicalTrials.gov/show/NCT02932956 |
Recruiting |
Baylor College of Medicine |
2022-01-31 |
| NCT02929082 |
Interest of elastoFRM With Force Measure by MRI on Patients With Hepatocellular Cancer |
https://ClinicalTrials.gov/show/NCT02929082 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-03-31 |
| NCT02156739 |
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions |
https://ClinicalTrials.gov/show/NCT02156739 |
Recruiting |
M.D. Anderson Cancer Center |
2021-10-31 |
| NCT02893982 |
High Dose Rate Brachyablation of Primary Liver Lesions |
https://ClinicalTrials.gov/show/NCT02893982 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2021-12-31 |
| NCT02886104 |
Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis |
https://ClinicalTrials.gov/show/NCT02886104 |
Recruiting |
Sixth Affiliated Hospital, Sun Yat-sen University |
2021-07-31 |
| NCT02881554 |
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery |
https://ClinicalTrials.gov/show/NCT02881554 |
Recruiting |
University of Washington |
2022-06-01 |
| NCT02864485 |
Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases |
https://ClinicalTrials.gov/show/NCT02864485 |
Recruiting |
University Health Network, Toronto |
2023-09-30 |
| NCT02853500 |
Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies |
https://ClinicalTrials.gov/show/NCT02853500 |
Recruiting |
Dana-Farber Cancer Institute |
2021-07-31 |
| NCT02850536 |
CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer |
https://ClinicalTrials.gov/show/NCT02850536 |
Active, not recruiting |
Roger Williams Medical Center |
2018-12-31 |
| NCT02849015 |
Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver |
https://ClinicalTrials.gov/show/NCT02849015 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2017-07-01 |
| NCT02843802 |
Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT02843802 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2017-07-01 |
| NCT02834780 |
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02834780 |
Recruiting |
Eisai Inc. |
2020-06-30 |
| NCT02829359 |
Effects of Antiviral Therapy on HBV Reactivation |
https://ClinicalTrials.gov/show/NCT02829359 |
Completed |
Guangxi Medical University |
2015-12-31 |
| NCT02825550 |
Taiwan ACE Beads for Hepatoma Embolization Therapy |
https://ClinicalTrials.gov/show/NCT02825550 |
Completed |
National Cheng-Kung University Hospital |
2016-12-31 |
| NCT02794337 |
TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer |
https://ClinicalTrials.gov/show/NCT02794337 |
Recruiting |
Tata Memorial Hospital |
2022-01-31 |
| NCT02760537 |
Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans |
https://ClinicalTrials.gov/show/NCT02760537 |
Completed |
Thomas Jefferson University |
2014-10-31 |
| NCT02727179 |
Open vs Laparoscopic Liver Surgery for Colorectal Liver Metastases |
https://ClinicalTrials.gov/show/NCT02727179 |
Completed |
Hospital Universitario Virgen de la Arrixaca |
2017-03-31 |
| NCT02716012 |
First-in-Human Safety and Tolerability Study of MTL-CEBPA in Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT02716012 |
Recruiting |
Mina Alpha Limited |
2019-03-31 |
| NCT02687113 |
Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US Fusion |
https://ClinicalTrials.gov/show/NCT02687113 |
Completed |
Seoul National University Hospital |
2015-01-31 |
| NCT02649868 |
LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors During Treatment With Transarterial Embolization (TAE) Alone or Combined With Thermal Ablation |
https://ClinicalTrials.gov/show/NCT02649868 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
2021-12-15 |
| NCT02649153 |
Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection |
https://ClinicalTrials.gov/show/NCT02649153 |
Recruiting |
Guangxi Medical University |
2020-12-30 |
| NCT02642978 |
Robot-assisted Procedure Versus Open Simultaneous Resection of Colorectal Cancer With Liver Metastases |
https://ClinicalTrials.gov/show/NCT02642978 |
Recruiting |
Fudan University |
2019-04-01 |
| NCT02632864 |
Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial |
https://ClinicalTrials.gov/show/NCT02632864 |
Recruiting |
Samsung Medical Center |
2019-10-31 |
| NCT02620228 |
Identification of Liver Tumours Using BIP - Biopsy System |
https://ClinicalTrials.gov/show/NCT02620228 |
Completed |
Injeq Ltd |
2017-12-31 |
| NCT02602327 |
Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases |
https://ClinicalTrials.gov/show/NCT02602327 |
Recruiting |
University of California, San Francisco |
2020-12-31 |
| NCT02597348 |
Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy |
https://ClinicalTrials.gov/show/NCT02597348 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2027-02-28 |
| NCT02582918 |
Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5 |
https://ClinicalTrials.gov/show/NCT02582918 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2022-08-31 |
| NCT01967823 |
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer |
https://ClinicalTrials.gov/show/NCT01967823 |
Completed |
National Institutes of Health Clinical Center (CC) |
2020-04-06 |
| NCT02038296 |
Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02038296 |
Completed |
Guangdong Provincial People’s Hospital |
2013-03-31 |
| NCT03408665 |
Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer |
https://ClinicalTrials.gov/show/NCT03408665 |
Recruiting |
Centre Oscar Lambret |
2026-03-13 |
| NCT02828865 |
A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers |
https://ClinicalTrials.gov/show/NCT02828865 |
Completed |
National Taiwan University Hospital |
2013-12-18 |
| NCT02571946 |
Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis |
https://ClinicalTrials.gov/show/NCT02571946 |
Recruiting |
Samsung Medical Center |
2019-09-30 |
| NCT02548910 |
Phlebotomy to Prevent Blood Loss in Major Hepatic Resections |
https://ClinicalTrials.gov/show/NCT02548910 |
Completed |
Ottawa Hospital Research Institute |
2018-03-31 |
| NCT02545556 |
Liver Cancer HepaSphere Combined With Cryosurgery |
https://ClinicalTrials.gov/show/NCT02545556 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2016-08-31 |
| NCT02536183 |
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02536183 |
Recruiting |
Children’s National Research Institute |
2020-10-31 |
| NCT02524925 |
Postoperative Stress Response in Patients Following Fast Track vs Conventional Protocol After Hepatectomy or Pancreatectomy |
https://ClinicalTrials.gov/show/NCT02524925 |
Completed |
National and Kapodistrian University of Athens |
2015-03-31 |
| NCT02511821 |
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery |
https://ClinicalTrials.gov/show/NCT02511821 |
Active, not recruiting |
City of Hope Medical Center |
2020-12-31 |
| NCT02511522 |
Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases |
https://ClinicalTrials.gov/show/NCT02511522 |
Recruiting |
Canadian Cancer Trials Group |
2020-06-30 |
| NCT02510378 |
Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases |
https://ClinicalTrials.gov/show/NCT02510378 |
Recruiting |
Chinese Academy of Medical Sciences |
2020-12-31 |
| NCT02471313 |
Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization |
https://ClinicalTrials.gov/show/NCT02471313 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-03-07 |
| NCT02461979 |
The Role of the Vitamin D Receptor Gene Polymorphisms in Hepatocarcinogenesis |
https://ClinicalTrials.gov/show/NCT02461979 |
Recruiting |
Tanta University |
2022-12-31 |
| NCT02461966 |
Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta |
https://ClinicalTrials.gov/show/NCT02461966 |
Completed |
Tanta University |
2016-04-30 |
| NCT02449109 |
Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma |
https://ClinicalTrials.gov/show/NCT02449109 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2016-02-29 |
| NCT02447263 |
HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer |
https://ClinicalTrials.gov/show/NCT02447263 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2016-02-29 |
| NCT02425735 |
Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer |
https://ClinicalTrials.gov/show/NCT02425735 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2016-06-30 |
| NCT02424955 |
Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation |
https://ClinicalTrials.gov/show/NCT02424955 |
Recruiting |
Stanford University |
2019-12-14 |
| NCT02416466 |
CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases |
https://ClinicalTrials.gov/show/NCT02416466 |
Completed |
Roger Williams Medical Center |
2016-11-21 |
| NCT02381561 |
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy |
https://ClinicalTrials.gov/show/NCT02381561 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-11-08 |
| NCT02352259 |
Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II |
https://ClinicalTrials.gov/show/NCT02352259 |
Completed |
Institute of Oncology Ljubljana |
2018-10-31 |
| NCT02338778 |
Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient |
https://ClinicalTrials.gov/show/NCT02338778 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2015-08-31 |
| NCT02329106 |
Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome |
https://ClinicalTrials.gov/show/NCT02329106 |
Recruiting |
Fuda Cancer Hospital, Guangzhou |
2020-12-01 |
| NCT02321202 |
Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT02321202 |
Completed |
Huazhong University of Science and Technology |
2013-09-30 |
| NCT02312817 |
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System |
https://ClinicalTrials.gov/show/NCT02312817 |
Completed |
University of Texas Southwestern Medical Center |
2017-08-31 |
| NCT02292173 |
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer |
https://ClinicalTrials.gov/show/NCT02292173 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2018-12-18 |
| NCT02291133 |
Treatment of Primary Liver Tumors With Electrochemotherapy (ECT) |
https://ClinicalTrials.gov/show/NCT02291133 |
Completed |
University Medical Centre Ljubljana |
2019-09-30 |
| NCT02271646 |
Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation |
https://ClinicalTrials.gov/show/NCT02271646 |
Completed |
Mahidol University |
2015-03-31 |
| NCT02264886 |
Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies |
https://ClinicalTrials.gov/show/NCT02264886 |
Completed |
Washington University School of Medicine |
2016-06-30 |
| NCT01522209 |
Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging |
https://ClinicalTrials.gov/show/NCT01522209 |
Completed |
Asklepios Kliniken Hamburg GmbH |
2014-12-31 |
| NCT02239900 |
Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02239900 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-08-31 |
| NCT02232490 |
Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L |
https://ClinicalTrials.gov/show/NCT02232490 |
Recruiting |
Immunitor LLC |
2019-11-30 |
| NCT02202317 |
Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors |
https://ClinicalTrials.gov/show/NCT02202317 |
Completed |
University of Miami |
2016-10-31 |
| NCT02201797 |
Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body |
https://ClinicalTrials.gov/show/NCT02201797 |
Completed |
Asan Medical Center |
2015-06-30 |
| NCT02192671 |
HR Versus RFA for HCC in Patients With PHT |
https://ClinicalTrials.gov/show/NCT02192671 |
Recruiting |
Guangxi Medical University |
2021-08-31 |
| NCT02191878 |
Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT02191878 |
Completed |
Arbutus Biopharma Corporation |
2016-05-31 |
| NCT02191761 |
Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT02191761 |
Completed |
Samumed LLC |
2015-05-20 |
| NCT02185768 |
Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II |
https://ClinicalTrials.gov/show/NCT02185768 |
Completed |
Federation Francophone de Cancerologie Digestive |
2018-05-31 |
| NCT02185443 |
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases |
https://ClinicalTrials.gov/show/NCT02185443 |
Recruiting |
University of Sao Paulo |
2021-05-31 |
| NCT02181075 |
Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours |
https://ClinicalTrials.gov/show/NCT02181075 |
Completed |
University of Oxford |
2017-03-31 |
| NCT02174549 |
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer |
https://ClinicalTrials.gov/show/NCT02174549 |
Active, not recruiting |
Teclison Ltd. |
2020-08-31 |
| NCT02172651 |
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases |
https://ClinicalTrials.gov/show/NCT02172651 |
Recruiting |
Dana-Farber Cancer Institute |
2020-12-31 |
| NCT02145559 |
A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02145559 |
Completed |
University of Chicago |
2016-11-15 |
| NCT02141906 |
A Pilot Study of “OncozeneTM” Microspheres for Intra-arterial Delivery of Doxorubicin |
https://ClinicalTrials.gov/show/NCT02141906 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2020-06-30 |
| NCT02094625 |
NAC to Prevent Cisplatin-induced Hearing Loss |
https://ClinicalTrials.gov/show/NCT02094625 |
Recruiting |
Children’s Hospital Los Angeles |
2021-01-31 |
| NCT02089919 |
Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients |
https://ClinicalTrials.gov/show/NCT02089919 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2015-02-28 |
| NCT02088775 |
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer |
https://ClinicalTrials.gov/show/NCT02088775 |
Active, not recruiting |
Fox Chase Cancer Center |
2016-09-08 |
| NCT02086656 |
PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES |
https://ClinicalTrials.gov/show/NCT02086656 |
Completed |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2017-03-30 |
| NCT02082210 |
A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT02082210 |
Completed |
Eli Lilly and Company |
2017-12-05 |
| NCT02076906 |
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors |
https://ClinicalTrials.gov/show/NCT02076906 |
Recruiting |
Children’s National Research Institute |
2020-10-31 |
| NCT02072486 |
Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02072486 |
Active, not recruiting |
Roswell Park Cancer Institute |
2020-07-03 |
| NCT02072356 |
Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02072356 |
Recruiting |
Ohio State University Comprehensive Cancer Center |
2027-08-31 |
| NCT02069145 |
Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer |
https://ClinicalTrials.gov/show/NCT02069145 |
Completed |
OncoMed Pharmaceuticals, Inc. |
2017-05-31 |
| NCT01306058 |
Sorafenib and TRC105 in Hepatocellular Cancer |
https://ClinicalTrials.gov/show/NCT01306058 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-06-01 |
| NCT02057146 |
Endoscopic Evaluation of Premalignant Lesions in the Biliary Tract and Pancreatic Ducts |
https://ClinicalTrials.gov/show/NCT02057146 |
Completed |
Karolinska University Hospital |
2019-08-22 |
| NCT02042443 |
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02042443 |
Completed |
National Cancer Institute (NCI) |
2017-01-31 |
| NCT02041065 |
Waterjet Versus Ultrasound Dissection During Hepatic Transection |
https://ClinicalTrials.gov/show/NCT02041065 |
Completed |
Karolinska University Hospital |
2015-02-28 |
| NCT02016391 |
Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours |
https://ClinicalTrials.gov/show/NCT02016391 |
Completed |
Uppsala University Hospital |
2014-12-31 |
| NCT03329950 |
A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT03329950 |
Recruiting |
Celldex Therapeutics |
2021-08-31 |
| NCT03267290 |
Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of CEUS and CEMRI Versus CECT and CEMRI |
https://ClinicalTrials.gov/show/NCT03267290 |
Completed |
National Taiwan University Hospital |
2018-11-29 |
| NCT02015169 |
Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis |
https://ClinicalTrials.gov/show/NCT02015169 |
Completed |
Samsung Medical Center |
2017-07-17 |
| NCT02013830 |
A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT02013830 |
Completed |
Hoffmann-La Roche |
2008-03-31 |
| NCT02010801 |
Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors |
https://ClinicalTrials.gov/show/NCT02010801 |
Completed |
National Taiwan University Hospital |
2013-12-31 |
| NCT01936233 |
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery |
https://ClinicalTrials.gov/show/NCT01936233 |
Recruiting |
Fudan University |
2021-12-31 |
| NCT01906021 |
Study of New Software Used During Ablations |
https://ClinicalTrials.gov/show/NCT01906021 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-08-01 |
| NCT01899261 |
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01899261 |
Completed |
Albert Einstein College of Medicine |
2016-05-09 |
| NCT01877187 |
Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT01877187 |
Completed |
Yale University |
2020-02-29 |
| NCT01862718 |
Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms |
https://ClinicalTrials.gov/show/NCT01862718 |
Completed |
National Institutes of Health Clinical Center (CC) |
2017-11-05 |
| NCT01853618 |
Tremelimumab With Chemoembolization or Ablation for Liver Cancer |
https://ClinicalTrials.gov/show/NCT01853618 |
Completed |
National Institutes of Health Clinical Center (CC) |
2017-06-07 |
| NCT02820194 |
A Trial on SBRT Versus MWA for Inoperable Colorectal Liver Metastases (CLM) |
https://ClinicalTrials.gov/show/NCT02820194 |
Recruiting |
Istituto Clinico Humanitas |
2021-02-28 |
| NCT01799044 |
Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver Metastases |
https://ClinicalTrials.gov/show/NCT01799044 |
Completed |
VU University Medical Center |
2013-09-30 |
| NCT01785212 |
The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver |
https://ClinicalTrials.gov/show/NCT01785212 |
Completed |
Medical University of Vienna |
2014-12-31 |
| NCT01782573 |
The Efficacy of Chlorhexidine Gluconate Pre - Disinfection Scrubbing in Preventing Surgical Site Infections for Hepatectomy Patients |
https://ClinicalTrials.gov/show/NCT01782573 |
Completed |
Changhua Christian Hospital |
2012-09-30 |
| NCT01775501 |
Sorafenib + mFOLFOX for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01775501 |
Completed |
Massachusetts General Hospital |
2018-07-31 |
| NCT01766219 |
CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01766219 |
Completed |
Wake Forest University Health Sciences |
2018-04-30 |
| NCT01754987 |
A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective |
https://ClinicalTrials.gov/show/NCT01754987 |
Completed |
Thomas Jefferson University |
2016-01-31 |
| NCT01749332 |
A Pilot Study of Perihepatic Phlebotomy During Hepatic Resections |
https://ClinicalTrials.gov/show/NCT01749332 |
Completed |
Memorial Sloan Kettering Cancer Center |
2019-12-31 |
| NCT04187937 |
Feasibility of Ultrasound-based Navigation for Non-anatomical Liver Resections |
https://ClinicalTrials.gov/show/NCT04187937 |
Recruiting |
University Hospital Inselspital, Berne |
2020-10-31 |
| NCT01743469 |
A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers |
https://ClinicalTrials.gov/show/NCT01743469 |
Completed |
Ipsen |
2014-12-31 |
| NCT01738217 |
Assessment of Indocyanine Green as a Near-Infrared Fluorescent Contrast Agent for Image-guided Liver Surgery |
https://ClinicalTrials.gov/show/NCT01738217 |
Completed |
Centre Leon Berard |
2015-05-31 |
| NCT01730937 |
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT01730937 |
Recruiting |
Radiation Therapy Oncology Group |
2024-06-30 |
| NCT01697371 |
Proton Therapy in the Treatment of Liver Metastases |
https://ClinicalTrials.gov/show/NCT01697371 |
Recruiting |
Loma Linda University |
2024-09-30 |
| NCT01666756 |
Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT01666756 |
Active, not recruiting |
City of Hope Medical Center |
2020-01-31 |
| NCT01643499 |
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies |
https://ClinicalTrials.gov/show/NCT01643499 |
Completed |
University of Chicago |
2016-08-28 |
| NCT01640522 |
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms |
https://ClinicalTrials.gov/show/NCT01640522 |
Completed |
University of Pittsburgh |
2013-12-31 |
| NCT01630239 |
MR-Guided Laser Ablation of Hepatic Tumors |
https://ClinicalTrials.gov/show/NCT01630239 |
Completed |
Mayo Clinic |
2015-03-31 |
| NCT01624285 |
Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT01624285 |
Active, not recruiting |
Jonsson Comprehensive Cancer Center |
2020-07-31 |
| NCT01612325 |
Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases |
https://ClinicalTrials.gov/show/NCT01612325 |
Completed |
UMC Utrecht |
2015-08-31 |
| NCT01596283 |
Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection |
https://ClinicalTrials.gov/show/NCT01596283 |
Completed |
Memorial Sloan Kettering Cancer Center |
2016-05-31 |
| NCT01528878 |
Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases |
https://ClinicalTrials.gov/show/NCT01528878 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2014-08-18 |
| NCT01525069 |
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01525069 |
Active, not recruiting |
Washington University School of Medicine |
2018-08-08 |
| NCT01522937 |
A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer |
https://ClinicalTrials.gov/show/NCT01522937 |
Completed |
University of Michigan Rogel Cancer Center |
2015-11-30 |
| NCT01502410 |
Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer |
https://ClinicalTrials.gov/show/NCT01502410 |
Completed |
National Cancer Institute (NCI) |
2014-06-30 |
| NCT01497444 |
Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01497444 |
Completed |
Alliance for Clinical Trials in Oncology |
2016-01-31 |
| NCT01494324 |
Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome |
https://ClinicalTrials.gov/show/NCT01494324 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2020-10-31 |
| NCT01493713 |
Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT01493713 |
Completed |
Grupo Espanol Multidisciplinario del Cancer Digestivo |
2014-12-08 |
| NCT01456156 |
Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01456156 |
Completed |
Chinese Academy of Medical Sciences |
2017-01-31 |
| NCT01438476 |
Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas |
https://ClinicalTrials.gov/show/NCT01438476 |
Completed |
M.D. Anderson Cancer Center |
2017-10-18 |
| NCT01425879 |
MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01425879 |
Completed |
National Cancer Institute (NCI) |
2013-05-31 |
| NCT01395030 |
PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection |
https://ClinicalTrials.gov/show/NCT01395030 |
Completed |
Queen’s Medical Centre |
2017-05-31 |
| NCT01394497 |
Use of N-Acetylcysteine During Liver Procurement |
https://ClinicalTrials.gov/show/NCT01394497 |
Completed |
Azienda Ospedaliera di Padova |
2009-07-31 |
| NCT01387555 |
A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib |
https://ClinicalTrials.gov/show/NCT01387555 |
Completed |
Jennerex Biotherapeutics |
2011-12-31 |
| NCT01375569 |
TRC105 for Liver Cancer That Has Not Responded to Sorafenib |
https://ClinicalTrials.gov/show/NCT01375569 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-02-01 |
| NCT01356628 |
A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT01356628 |
Active, not recruiting |
Thomas Jefferson University |
2015-04-09 |
| NCT01347333 |
Stereotactic Body Radiotherapy for Liver Tumors |
https://ClinicalTrials.gov/show/NCT01347333 |
Completed |
Mercy Research |
2016-09-30 |
| NCT04348643 |
Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer |
https://ClinicalTrials.gov/show/NCT04348643 |
Recruiting |
Chongqing Precision Biotech Co., Ltd |
2023-01-31 |
| NCT04295330 |
Lidocaine Combined With Low Opioid Anesthesia and Analgesia in Patients With Primary Liver Cancer |
https://ClinicalTrials.gov/show/NCT04295330 |
Recruiting |
West China Hospital |
2021-01-15 |
| NCT04272619 |
Liver Cancer Community Education |
https://ClinicalTrials.gov/show/NCT04272619 |
Recruiting |
Fox Chase Cancer Center |
2020-08-31 |
| NCT04269499 |
Real-time Imaging of Holmium Radioembolization: a Feasibility Study |
https://ClinicalTrials.gov/show/NCT04269499 |
Recruiting |
Radboud University |
2020-07-31 |
| NCT04242342 |
Adaptative MR-Guided Stereotactic Body Radiotherapy of Liver Tumors |
https://ClinicalTrials.gov/show/NCT04242342 |
Recruiting |
Centre Georges Francois Leclerc |
2025-12-02 |
| NCT04241887 |
Is Thoracic Paravertebral Block a Better Option Than Conscious Sedation for PRFA of Liver Tumors |
https://ClinicalTrials.gov/show/NCT04241887 |
Completed |
University of Warmia and Mazury |
2018-12-12 |
| NCT04218253 |
Clinical Application of Nutrition Support Package Before Hepatectomy |
https://ClinicalTrials.gov/show/NCT04218253 |
Recruiting |
Tianjin Medical University Cancer Institute and Hospital |
2021-09-30 |
| NCT04212286 |
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC |
https://ClinicalTrials.gov/show/NCT04212286 |
Recruiting |
Tianjin Third Central Hospital |
2021-12-31 |
| NCT04212273 |
Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCC |
https://ClinicalTrials.gov/show/NCT04212273 |
Recruiting |
Tianjin Third Central Hospital |
2021-12-24 |
| NCT04212221 |
MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients |
https://ClinicalTrials.gov/show/NCT04212221 |
Recruiting |
Zai Lab (Shanghai) Co., Ltd. |
2022-12-31 |
| NCT04204577 |
The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT04204577 |
Recruiting |
Chinese PLA General Hospital |
2021-11-30 |
| NCT04196465 |
Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT04196465 |
Recruiting |
Asan Medical Center |
2026-09-09 |
| NCT04186234 |
SBRT for Liver Cancer Before Liver Transplantation |
https://ClinicalTrials.gov/show/NCT04186234 |
Recruiting |
The University of Hong Kong |
2020-12-31 |
| NCT04178759 |
Impact of Chemotherapy and Regenerative Markers of Liver Regeneration After Liver Resection for Liver Metastases |
https://ClinicalTrials.gov/show/NCT04178759 |
Recruiting |
Vilnius University |
2022-04-01 |
| NCT04172714 |
Low-dose Y90 Treatment Planning for HCC |
https://ClinicalTrials.gov/show/NCT04172714 |
Recruiting |
Emory University |
2021-06-30 |
| NCT04166240 |
Measuring and Improving the Safety of Test Result Follow-Up |
https://ClinicalTrials.gov/show/NCT04166240 |
Active, not recruiting |
VA Office of Research and Development |
2022-04-01 |
| NCT04163237 |
Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT04163237 |
Recruiting |
Guangxi Medical University |
2020-10-31 |
| NCT04143516 |
Tissue Analysis After Thermal Ablation for Colon Cancer Liver Metastases Leading to Immediate Retreatment |
https://ClinicalTrials.gov/show/NCT04143516 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2022-10-31 |
| NCT04134559 |
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04134559 |
Recruiting |
Dana-Farber Cancer Institute |
2023-01-01 |
| NCT04123340 |
Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation |
https://ClinicalTrials.gov/show/NCT04123340 |
Recruiting |
Leiden University Medical Center |
2020-10-01 |
| NCT04106453 |
Navigated Laparoscopic Microwave Ablation of Tumor Mimics in Pig Liver - an Ex-vivo Trial |
https://ClinicalTrials.gov/show/NCT04106453 |
Completed |
Universitätsklinikum Köln |
2020-01-14 |
| NCT04090645 |
TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer |
https://ClinicalTrials.gov/show/NCT04090645 |
Recruiting |
Methodist Health System |
2025-05-31 |
| NCT04083378 |
Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study |
https://ClinicalTrials.gov/show/NCT04083378 |
Recruiting |
M.D. Anderson Cancer Center |
2022-12-31 |
| NCT04033107 |
High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors |
https://ClinicalTrials.gov/show/NCT04033107 |
Recruiting |
Zhongnan Hospital |
2022-06-30 |
| NCT04020276 |
OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases |
https://ClinicalTrials.gov/show/NCT04020276 |
Recruiting |
University of Wisconsin, Madison |
2023-08-01 |
| NCT04008797 |
A Study of E7386 in Combination With Other Anticancer Drug in Participants With Solid Tumor |
https://ClinicalTrials.gov/show/NCT04008797 |
Recruiting |
Eisai Inc. |
2021-03-27 |
| NCT03998033 |
Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03998033 |
Recruiting |
Eureka Therapeutics Inc. |
2022-07-01 |
| NCT03979547 |
EXALT: EXercise Attenuates Liver Tumors Trial |
https://ClinicalTrials.gov/show/NCT03979547 |
Recruiting |
Milton S. Hershey Medical Center |
2021-12-31 |
| NCT03965546 |
ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer |
https://ClinicalTrials.gov/show/NCT03965546 |
Recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2021-06-30 |
| NCT03949231 |
Infusion of Toripalimab Via Hepatic Arterial Versus Vein for Immunotherapy of Advanced Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03949231 |
Recruiting |
Second Affiliated Hospital of Guangzhou Medical University |
2021-01-01 |
| NCT03942328 |
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer |
https://ClinicalTrials.gov/show/NCT03942328 |
Recruiting |
Mayo Clinic |
2022-05-01 |
| NCT03895970 |
Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors |
https://ClinicalTrials.gov/show/NCT03895970 |
Recruiting |
Peking Union Medical College Hospital |
2020-04-01 |
| NCT03895723 |
Minimally Invasive Versus Open Liver Resection for Patients With Colorectal Cancer Liver Metastases |
https://ClinicalTrials.gov/show/NCT03895723 |
Recruiting |
Fudan University |
2021-04-01 |
| NCT03891654 |
Dynamic Contrast Enhanced Computed Tomography to Assess Radiation Therapy in Liver Cancer Patients |
https://ClinicalTrials.gov/show/NCT03891654 |
Recruiting |
University of Colorado, Denver |
2021-01-31 |
| NCT03888859 |
ET1402L1-ARTEMISâ„¢2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03888859 |
Recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2019-12-06 |
| NCT03856658 |
Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases |
https://ClinicalTrials.gov/show/NCT03856658 |
Recruiting |
Spectrum Health Hospitals |
2020-04-30 |
| NCT03843229 |
Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer |
https://ClinicalTrials.gov/show/NCT03843229 |
Recruiting |
The First Affiliated Hospital of Dalian Medical University |
2020-09-01 |
| NCT03803436 |
Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation |
https://ClinicalTrials.gov/show/NCT03803436 |
Recruiting |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2024-01-31 |
| NCT03787056 |
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients |
https://ClinicalTrials.gov/show/NCT03787056 |
Recruiting |
Hospices Civils de Lyon |
2026-11-30 |
| NCT03781934 |
A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations |
https://ClinicalTrials.gov/show/NCT03781934 |
Recruiting |
Medivir |
2021-12-31 |
| NCT03753789 |
Ablation Confirmation Study |
https://ClinicalTrials.gov/show/NCT03753789 |
Recruiting |
Ethicon, Inc. |
2021-10-29 |
| NCT03744624 |
Application of 3D Printing in Laparoscopic Surgery of Liver Tumors |
https://ClinicalTrials.gov/show/NCT03744624 |
Recruiting |
Jagiellonian University |
2021-12-31 |
| NCT03715517 |
Spinal Anesthesia For Enhanced Recovery After Liver Surgery |
https://ClinicalTrials.gov/show/NCT03715517 |
Recruiting |
University of Manitoba |
2019-11-30 |
| NCT03687853 |
Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery |
https://ClinicalTrials.gov/show/NCT03687853 |
Enrolling by invitation |
Peking University Third Hospital |
2018-12-31 |
| NCT03680508 |
TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT03680508 |
Recruiting |
University of Hawaii |
2022-10-31 |
| NCT03651154 |
Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections |
https://ClinicalTrials.gov/show/NCT03651154 |
Recruiting |
Ottawa Hospital Research Institute |
2022-10-31 |
| NCT03623464 |
RCT of Mobile Apps & FitBit v. Usual Care |
https://ClinicalTrials.gov/show/NCT03623464 |
Recruiting |
Weill Medical College of Cornell University |
2021-06-30 |
| NCT03594929 |
Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery |
https://ClinicalTrials.gov/show/NCT03594929 |
Recruiting |
Singapore General Hospital |
2019-01-18 |
| NCT03594188 |
Effects of Anesthetic Methods on Hepatic Cancer Cell Malignancy |
https://ClinicalTrials.gov/show/NCT03594188 |
Completed |
RenJi Hospital |
2019-07-31 |
| NCT03592706 |
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy |
https://ClinicalTrials.gov/show/NCT03592706 |
Recruiting |
Ivy Life Sciences, Co., Ltd |
2021-02-28 |
| NCT03590119 |
Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases |
https://ClinicalTrials.gov/show/NCT03590119 |
Recruiting |
UMC Utrecht |
2021-09-01 |
| NCT03586050 |
Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea |
https://ClinicalTrials.gov/show/NCT03586050 |
Recruiting |
Ethicon, Inc. |
2020-09-30 |
| NCT03579199 |
Practical Application of Indocyanine Green Camera in Laparoscopic Liver Surgery |
https://ClinicalTrials.gov/show/NCT03579199 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-03-31 |
| NCT03572582 |
Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03572582 |
Recruiting |
AIO-Studien-gGmbH |
2021-12-31 |
| NCT03533582 |
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery |
https://ClinicalTrials.gov/show/NCT03533582 |
Recruiting |
Children’s Oncology Group |
2025-06-30 |
| NCT03488953 |
Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver Metastases |
https://ClinicalTrials.gov/show/NCT03488953 |
Recruiting |
Jena University Hospital |
2023-06-30 |
| NCT03484962 |
Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT03484962 |
Recruiting |
Fuda Cancer Hospital, Guangzhou |
2020-05-25 |
| NCT03474822 |
Plasmodium Immunotherapy for Breast and Liver Cancers |
https://ClinicalTrials.gov/show/NCT03474822 |
Recruiting |
CAS Lamvac Biotech Co., Ltd. |
2021-12-31 |
| NCT03441100 |
TCR-engineered T Cells in Solid Tumors Including NSCLC and HCC Patients |
https://ClinicalTrials.gov/show/NCT03441100 |
Recruiting |
Immatics US, Inc. |
2020-09-30 |
| NCT03428477 |
EPA for Metastasis Trial 2 |
https://ClinicalTrials.gov/show/NCT03428477 |
Recruiting |
University of Leeds |
2022-01-31 |
| NCT01264952 |
Treatment of Liver Metastases With Electrochemotherapy |
https://ClinicalTrials.gov/show/NCT01264952 |
Completed |
Institute of Oncology Ljubljana |
2013-03-31 |
| NCT01264705 |
Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT01264705 |
Completed |
University of Texas Southwestern Medical Center |
2018-04-30 |
| NCT01260415 |
A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases |
https://ClinicalTrials.gov/show/NCT01260415 |
Completed |
University Health Network, Toronto |
2013-06-30 |
| NCT01255007 |
Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases |
https://ClinicalTrials.gov/show/NCT01255007 |
Completed |
University Health Network, Toronto |
2014-07-31 |
| NCT01239381 |
Individualized Stereotactic Body Radiotherapy of Liver Metastases |
https://ClinicalTrials.gov/show/NCT01239381 |
Completed |
Massachusetts General Hospital |
2016-01-31 |
| NCT01219985 |
Benefits Study of Respiratory-gated Positron Emission Tomography Acquisitions of the Liver |
https://ClinicalTrials.gov/show/NCT01219985 |
Completed |
Centre Hospitalier Universitaire, Amiens |
2009-12-31 |
| NCT01218854 |
A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy |
https://ClinicalTrials.gov/show/NCT01218854 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-11-16 |
| NCT01186263 |
Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy |
https://ClinicalTrials.gov/show/NCT01186263 |
Completed |
University of Magdeburg |
2011-07-31 |
| NCT01177007 |
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors |
https://ClinicalTrials.gov/show/NCT01177007 |
Completed |
Yale University |
2014-08-31 |
| NCT01171924 |
A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors |
https://ClinicalTrials.gov/show/NCT01171924 |
Completed |
Curis, Inc. |
2011-10-31 |
| NCT01164202 |
Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT01164202 |
Completed |
Federation Francophone de Cancerologie Digestive |
2017-07-31 |
| NCT01149304 |
Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity |
https://ClinicalTrials.gov/show/NCT01149304 |
Completed |
University of Magdeburg |
2017-11-15 |
| NCT01120288 |
A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases |
https://ClinicalTrials.gov/show/NCT01120288 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01096914 |
Radiofrequency Versus Laser Ablation for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT01096914 |
Completed |
Cardarelli Hospital |
2012-09-30 |
| NCT01075555 |
Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis |
https://ClinicalTrials.gov/show/NCT01075555 |
Completed |
Federation Francophone de Cancerologie Digestive |
2015-09-30 |
| NCT01075399 |
Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors |
https://ClinicalTrials.gov/show/NCT01075399 |
Completed |
Siemens Molecular Imaging |
2011-05-31 |
| NCT01075113 |
Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT01075113 |
Completed |
Virginia Commonwealth University |
2017-02-02 |
| NCT01071941 |
rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors |
https://ClinicalTrials.gov/show/NCT01071941 |
Recruiting |
Massachusetts General Hospital |
2020-07-31 |
| NCT01061840 |
Trial of Bi-shRNA-furin and Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented Autologous Tumor Cell Vaccine for Advanced Cancer |
https://ClinicalTrials.gov/show/NCT01061840 |
Completed |
Gradalis, Inc. |
2018-12-06 |
| NCT01042041 |
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer |
https://ClinicalTrials.gov/show/NCT01042041 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2010-12-31 |
| NCT01033240 |
CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT01033240 |
Completed |
Daiichi Sankyo, Inc. |
2014-11-30 |
| NCT01082224 |
Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy |
https://ClinicalTrials.gov/show/NCT01082224 |
Active, not recruiting |
American College of Radiology Imaging Network |
2022-12-31 |
| NCT01031784 |
Radioactive Holmium Microspheres for the Treatment of Liver Metastases |
https://ClinicalTrials.gov/show/NCT01031784 |
Completed |
UMC Utrecht |
2011-12-31 |
| NCT01011010 |
Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01011010 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2012-12-31 |
| NCT01010126 |
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer |
https://ClinicalTrials.gov/show/NCT01010126 |
Completed |
National Cancer Institute (NCI) |
2017-03-13 |
| NCT01008566 |
Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT01008566 |
Completed |
National Cancer Institute (NCI) |
2016-05-31 |
| NCT01005199 |
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT01005199 |
Completed |
Swiss Group for Clinical Cancer Research |
2013-06-30 |
| NCT00997022 |
Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients |
https://ClinicalTrials.gov/show/NCT00997022 |
Completed |
Columbia University |
2015-05-31 |
| NCT00987766 |
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer |
https://ClinicalTrials.gov/show/NCT00987766 |
Completed |
Vanderbilt-Ingram Cancer Center |
2013-07-31 |
| NCT00976898 |
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00976898 |
Completed |
Massachusetts General Hospital |
2017-03-31 |
| NCT00969410 |
A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases |
https://ClinicalTrials.gov/show/NCT00969410 |
Completed |
AVEO Pharmaceuticals, Inc. |
2011-03-31 |
| NCT00960557 |
Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden |
https://ClinicalTrials.gov/show/NCT00960557 |
Completed |
Mateon Therapeutics |
2010-10-31 |
| NCT00957424 |
Acceptability of Less Harmful Alternatives to Cigarettes |
https://ClinicalTrials.gov/show/NCT00957424 |
Completed |
Roswell Park Cancer Institute |
2009-08-31 |
| NCT00956930 |
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery |
https://ClinicalTrials.gov/show/NCT00956930 |
Completed |
Northwestern University |
2016-06-02 |
| NCT00949182 |
Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00949182 |
Completed |
Rutgers, The State University of New Jersey |
2013-06-30 |
| NCT00941967 |
Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT00941967 |
Completed |
Institut du Cancer de Montpellier - Val d’Aurelle |
2010-12-31 |
| NCT00923897 |
Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4) |
https://ClinicalTrials.gov/show/NCT00923897 |
Completed |
University Health Network, Toronto |
2018-09-26 |
| NCT00922181 |
Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT00922181 |
Completed |
University Hospital, Gasthuisberg |
2009-04-30 |
| NCT00914615 |
Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3) |
https://ClinicalTrials.gov/show/NCT00914615 |
Active, not recruiting |
University Health Network, Toronto |
2019-08-16 |
| NCT00902343 |
Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection |
https://ClinicalTrials.gov/show/NCT00902343 |
Completed |
Memorial Sloan Kettering Cancer Center |
2015-04-30 |
| NCT00888407 |
Community-based Hepatitis B Interventions for Hmong Adults |
https://ClinicalTrials.gov/show/NCT00888407 |
Completed |
University of California, Davis |
2011-08-31 |
| NCT00881751 |
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT00881751 |
Completed |
Medical University of South Carolina |
2016-05-31 |
| NCT00875615 |
Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00875615 |
Completed |
University of Miami |
2012-06-30 |
| NCT00870558 |
Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer |
https://ClinicalTrials.gov/show/NCT00870558 |
Completed |
National Cancer Institute (NCI) |
2011-05-31 |
| NCT00869843 |
Study of Saline Linked Monopolar Surface Radiofrequency (RF) Ablation of Hepatic Tumors |
https://ClinicalTrials.gov/show/NCT00869843 |
Completed |
Washington University School of Medicine |
2007-10-31 |
| NCT00869271 |
Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00869271 |
Completed |
Fudan University |
2007-12-31 |
| NCT00867321 |
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT00867321 |
Completed |
Alliance for Clinical Trials in Oncology |
2012-04-30 |
| NCT00866944 |
Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases |
https://ClinicalTrials.gov/show/NCT00866944 |
Completed |
Amgen Research (Munich) GmbH |
2011-07-31 |
| NCT00861783 |
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma |
https://ClinicalTrials.gov/show/NCT00861783 |
Completed |
Onconova Therapeutics, Inc. |
2011-07-31 |
| NCT00858429 |
Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases |
https://ClinicalTrials.gov/show/NCT00858429 |
Completed |
Northwestern University |
2014-03-19 |
| NCT00848510 |
EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases |
https://ClinicalTrials.gov/show/NCT00848510 |
Completed |
Merck KGaA, Darmstadt, Germany |
2013-11-30 |
| NCT00844168 |
Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant |
https://ClinicalTrials.gov/show/NCT00844168 |
Completed |
University of Washington |
2010-06-30 |
| NCT04079049 |
BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases |
https://ClinicalTrials.gov/show/NCT04079049 |
Recruiting |
Umeå University |
2029-12-31 |
| NCT00829413 |
SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization |
https://ClinicalTrials.gov/show/NCT00829413 |
Completed |
Bracco Diagnostics, Inc |
2013-07-31 |
| NCT00825955 |
Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment |
https://ClinicalTrials.gov/show/NCT00825955 |
Completed |
Bristol-Myers Squibb |
2011-11-15 |
| NCT00824707 |
Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer |
https://ClinicalTrials.gov/show/NCT00824707 |
Completed |
Eastern Hepatobiliary Surgery Hospital |
2010-11-30 |
| NCT00822562 |
Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer |
https://ClinicalTrials.gov/show/NCT00822562 |
Completed |
Eastern Hepatobiliary Surgery Hospital |
2009-01-31 |
| NCT04323618 |
Investigation of Respiratory-related Tumour Motion in Liver Cancer Patients Undergoing SBRT Using Audiovisual Biofeedback |
https://ClinicalTrials.gov/show/NCT04323618 |
Completed |
University of Sydney |
2018-04-30 |
| NCT03926039 |
Sharing Decision-making Program for HCC Patients Treatment Decisions |
https://ClinicalTrials.gov/show/NCT03926039 |
Recruiting |
National Taipei University of Nursing and Health Sciences |
2020-10-31 |
| NCT03889093 |
Immunologic Effects of Radioembolization of Primary and Secondary Liver Malignancies |
https://ClinicalTrials.gov/show/NCT03889093 |
Recruiting |
University of Minnesota |
2020-08-01 |
| NCT03674073 |
A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03674073 |
Recruiting |
Chinese PLA General Hospital |
2020-10-15 |
| NCT00813293 |
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer |
https://ClinicalTrials.gov/show/NCT00813293 |
Completed |
Dana-Farber Cancer Institute |
2013-11-30 |
| NCT04195438 |
Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy |
https://ClinicalTrials.gov/show/NCT04195438 |
Recruiting |
University of Maryland, Baltimore |
2021-12-31 |
| NCT01516710 |
Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study |
https://ClinicalTrials.gov/show/NCT01516710 |
Active, not recruiting |
Oslo University Hospital |
2016-04-30 |
| NCT01373047 |
CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells |
https://ClinicalTrials.gov/show/NCT01373047 |
Completed |
Roger Williams Medical Center |
2013-07-31 |
| NCT03963726 |
Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer. |
https://ClinicalTrials.gov/show/NCT03963726 |
Recruiting |
Peking University Third Hospital |
2021-05-31 |
| NCT02911961 |
APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors |
https://ClinicalTrials.gov/show/NCT02911961 |
Recruiting |
Denver Health and Hospital Authority |
2020-06-30 |
| NCT02784353 |
Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy |
https://ClinicalTrials.gov/show/NCT02784353 |
Recruiting |
Asan Medical Center |
2019-12-31 |
| NCT02578602 |
MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT02578602 |
Completed |
University of Southern California |
2014-11-30 |
| NCT02509507 |
Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab |
https://ClinicalTrials.gov/show/NCT02509507 |
Recruiting |
Amgen |
2022-10-25 |
| NCT02044224 |
Effects of Dexmedetomidine During IRE Procedures for Solid Tumours |
https://ClinicalTrials.gov/show/NCT02044224 |
Completed |
Uppsala University Hospital |
2015-09-30 |
| NCT02018107 |
PET/CT-Assessment of Liver Tumor Ablation |
https://ClinicalTrials.gov/show/NCT02018107 |
Completed |
Dana-Farber Cancer Institute |
2018-02-16 |
| NCT01880554 |
Ultrasound Liver Intraoperative Imaging With SonoVue® |
https://ClinicalTrials.gov/show/NCT01880554 |
Completed |
Institut Bergonié |
2016-09-30 |
| NCT03867916 |
Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients |
https://ClinicalTrials.gov/show/NCT03867916 |
Recruiting |
University of California, San Francisco |
2021-02-28 |
| NCT01180959 |
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy |
https://ClinicalTrials.gov/show/NCT01180959 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-03-01 |
| NCT00790569 |
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking |
https://ClinicalTrials.gov/show/NCT00790569 |
Completed |
Butler Hospital |
2012-10-31 |
| NCT00788697 |
SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization |
https://ClinicalTrials.gov/show/NCT00788697 |
Completed |
Bracco Diagnostics, Inc |
2013-07-31 |
| NCT00788125 |
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors |
https://ClinicalTrials.gov/show/NCT00788125 |
Active, not recruiting |
City of Hope Medical Center |
2023-09-30 |
| NCT00777894 |
Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00777894 |
Completed |
Swiss Group for Clinical Cancer Research |
2014-01-31 |
| NCT00775073 |
Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001 |
https://ClinicalTrials.gov/show/NCT00775073 |
Completed |
Treiber, Gerhard |
2011-01-31 |
| NCT00774501 |
The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During Radiotherapy |
https://ClinicalTrials.gov/show/NCT00774501 |
Completed |
Memorial Sloan Kettering Cancer Center |
2016-02-29 |
| NCT00743678 |
Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis |
https://ClinicalTrials.gov/show/NCT00743678 |
Completed |
Samsung Medical Center |
2012-01-31 |
| NCT00740753 |
Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an Option |
https://ClinicalTrials.gov/show/NCT00740753 |
Enrolling by invitation |
OHSU Knight Cancer Institute |
2025-01-31 |
| NCT00732836 |
Hepatic Arterial Infusion (HAI) of Abraxane |
https://ClinicalTrials.gov/show/NCT00732836 |
Completed |
M.D. Anderson Cancer Center |
2016-01-31 |
| NCT00724503 |
FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00724503 |
Completed |
Sirtex Medical |
2015-05-31 |
| NCT00716976 |
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy |
https://ClinicalTrials.gov/show/NCT00716976 |
Completed |
Children’s Oncology Group |
2015-04-30 |
| NCT00706576 |
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor |
https://ClinicalTrials.gov/show/NCT00706576 |
Completed |
University of Missouri-Columbia |
2013-07-31 |
| NCT00666978 |
Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking |
https://ClinicalTrials.gov/show/NCT00666978 |
Completed |
University of Kansas Medical Center |
2010-06-30 |
| NCT00654160 |
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00654160 |
Completed |
Mayo Clinic |
2010-11-30 |
| NCT00652132 |
Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer |
https://ClinicalTrials.gov/show/NCT00652132 |
Completed |
University of Birmingham |
2017-09-04 |
| NCT00629759 |
A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma |
https://ClinicalTrials.gov/show/NCT00629759 |
Completed |
Jennerex Biotherapeutics |
2007-07-31 |
| NCT00614913 |
Proton Beam Therapy for Treatment of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00614913 |
Completed |
Loma Linda University |
2009-02-28 |
| NCT00607828 |
Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT00607828 |
Completed |
University of Nebraska |
2017-02-15 |
| NCT00605722 |
A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer. |
https://ClinicalTrials.gov/show/NCT00605722 |
Completed |
Hoffmann-La Roche |
2010-09-30 |
| NCT00604721 |
Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT00604721 |
Completed |
National Cancer Institute (NCI) |
2012-06-30 |
| NCT00604409 |
Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00604409 |
Completed |
Fox Chase Cancer Center |
2014-06-30 |
| NCT00600613 |
Assess the Feasibility of Cone Beam CT to Localize Liver Metastases Immediately Prior to Radiotherapy |
https://ClinicalTrials.gov/show/NCT00600613 |
Completed |
Memorial Sloan Kettering Cancer Center |
2010-10-31 |
| NCT00587067 |
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy |
https://ClinicalTrials.gov/show/NCT00587067 |
Completed |
Memorial Sloan Kettering Cancer Center |
2016-05-19 |
| NCT00584402 |
Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation |
https://ClinicalTrials.gov/show/NCT00584402 |
Completed |
University of California, Davis |
2009-03-31 |
| NCT00576199 |
A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT00576199 |
Completed |
Hoffmann-La Roche |
2011-05-31 |
| NCT00575523 |
Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy |
https://ClinicalTrials.gov/show/NCT00575523 |
Completed |
Medical University of Vienna |
NA |
| NCT00557557 |
Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases |
https://ClinicalTrials.gov/show/NCT00557557 |
Completed |
University of Pittsburgh |
2012-03-31 |
| NCT00543777 |
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease |
https://ClinicalTrials.gov/show/NCT00543777 |
Completed |
M.D. Anderson Cancer Center |
2020-01-13 |
| NCT00539643 |
Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00539643 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-02-28 |
| NCT00539253 |
Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. |
https://ClinicalTrials.gov/show/NCT00539253 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2013-03-31 |
| NCT00537121 |
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00537121 |
Completed |
Roswell Park Cancer Institute |
2012-10-31 |
| NCT00534001 |
Bupropion in Helping Adults Stop Smoking |
https://ClinicalTrials.gov/show/NCT00534001 |
Completed |
Roswell Park Cancer Institute |
2008-05-31 |
| NCT00514228 |
Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00514228 |
Completed |
Swiss Group for Clinical Cancer Research |
2008-08-31 |
| NCT00513461 |
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection |
https://ClinicalTrials.gov/show/NCT00513461 |
Completed |
University of California, Irvine |
2012-08-31 |
| NCT00507585 |
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin |
https://ClinicalTrials.gov/show/NCT00507585 |
Completed |
M.D. Anderson Cancer Center |
2010-01-31 |
| NCT00501605 |
Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases |
https://ClinicalTrials.gov/show/NCT00501605 |
Completed |
AstraZeneca |
2005-04-30 |
| NCT00493883 |
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors |
https://ClinicalTrials.gov/show/NCT00493883 |
Completed |
Southwestern Regional Medical Center |
2011-12-31 |
| NCT00486356 |
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00486356 |
Completed |
University of Nebraska |
2010-01-31 |
| NCT00483405 |
Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT00483405 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2010-02-28 |
| NCT00467194 |
Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00467194 |
Completed |
National Cancer Centre, Singapore |
2011-05-31 |
| NCT00465023 |
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases |
https://ClinicalTrials.gov/show/NCT00465023 |
Completed |
Massachusetts General Hospital |
2013-09-30 |
| NCT01099631 |
IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread |
https://ClinicalTrials.gov/show/NCT01099631 |
Completed |
Masonic Cancer Center, University of Minnesota |
2014-01-31 |
| NCT00019630 |
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00019630 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00441376 |
A Study of ThermoDoxâ„¢ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver |
https://ClinicalTrials.gov/show/NCT00441376 |
Completed |
Celsion |
2008-10-31 |
| NCT00440310 |
Phase 3 Trial of Litxâ„¢ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases |
https://ClinicalTrials.gov/show/NCT00440310 |
Completed |
Light Sciences Oncology |
2011-05-31 |
| NCT00436410 |
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00436410 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00410956 |
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00410956 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-07-31 |
| NCT00397384 |
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00397384 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT00392366 |
Laser Interstitial Thermal Therapy Under “Real Time” MRI Guidance for “Minimal Invasive” Treatment of Liver Metastasis |
https://ClinicalTrials.gov/show/NCT00392366 |
Completed |
BioTex, Inc. |
NA |
| NCT00376987 |
Zinc Supplements in Lowering Cadmium Levels in Smokers |
https://ClinicalTrials.gov/show/NCT00376987 |
Completed |
Wake Forest University Health Sciences |
2006-10-31 |
| NCT00365508 |
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking |
https://ClinicalTrials.gov/show/NCT00365508 |
Completed |
Fox Chase Cancer Center |
2009-08-31 |
| NCT00365391 |
Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT00365391 |
Completed |
National Cancer Institute (NCI) |
2008-08-31 |
| NCT00363584 |
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00363584 |
Completed |
National Cancer Institute (NCI) |
2013-08-31 |
| NCT00361309 |
SU011248 in Advanced Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00361309 |
Completed |
Massachusetts General Hospital |
2007-11-30 |
| NCT00355355 |
A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT00355355 |
Completed |
Light Sciences Oncology |
2012-09-30 |
| NCT00335829 |
Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00335829 |
Completed |
Yale University |
2011-02-28 |
| NCT00327652 |
Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases |
https://ClinicalTrials.gov/show/NCT00327652 |
Completed |
Anza Therapeutics, Inc. |
2008-02-29 |
| NCT00321594 |
Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00321594 |
Completed |
National Cancer Institute (NCI) |
2010-08-31 |
| NCT00307866 |
Identification of Hepatic Lesions |
https://ClinicalTrials.gov/show/NCT00307866 |
Completed |
Bayer |
NA |
| NCT00304135 |
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00304135 |
Completed |
Federation Francophone de Cancerologie Digestive |
2012-12-31 |
| NCT00303940 |
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors |
https://ClinicalTrials.gov/show/NCT00303940 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00293397 |
Chemoembolization Using Doxorubicin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00293397 |
Completed |
Yale University |
2011-04-30 |
| NCT00257426 |
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT00257426 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2007-02-28 |
| NCT00247676 |
An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer |
https://ClinicalTrials.gov/show/NCT00247676 |
Completed |
Pfizer |
2008-02-29 |
| NCT00242502 |
Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00242502 |
Completed |
M.D. Anderson Cancer Center |
2011-10-31 |
| NCT00242086 |
Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases |
https://ClinicalTrials.gov/show/NCT00242086 |
Completed |
University Health Network, Toronto |
2010-03-31 |
| NCT00238394 |
Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT00238394 |
Completed |
National Cancer Institute (NCI) |
2007-03-31 |
| NCT00222664 |
Qidong Hepatitis B Intervention Study |
https://ClinicalTrials.gov/show/NCT00222664 |
Completed |
University of Oxford |
NA |
| NCT00208260 |
Intensified Chemotherapy in CRC After Resection of Liver Metastases |
https://ClinicalTrials.gov/show/NCT00208260 |
Completed |
Institut du Cancer de Montpellier - Val d’Aurelle |
NA |
| NCT00200200 |
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00200200 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-11-30 |
| NCT00199173 |
Comparing Hepatic Intra-arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only |
https://ClinicalTrials.gov/show/NCT00199173 |
Completed |
Jules Bordet Institute |
2010-01-31 |
| NCT00191412 |
A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver |
https://ClinicalTrials.gov/show/NCT00191412 |
Completed |
Eli Lilly and Company |
NA |
| NCT00187109 |
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy |
https://ClinicalTrials.gov/show/NCT00187109 |
Completed |
St. Jude Children’s Research Hospital |
2007-02-28 |
| NCT00178243 |
Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation |
https://ClinicalTrials.gov/show/NCT00178243 |
Completed |
University of Rochester |
NA |
| NCT00168155 |
Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT00168155 |
Completed |
AHS Cancer Control Alberta |
2009-05-31 |
| NCT00153998 |
Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM) |
https://ClinicalTrials.gov/show/NCT00153998 |
Completed |
Technische Universität Dresden |
2008-03-31 |
| NCT00152906 |
Stereotactic Radiotherapy (SRT) Liver (COLD 1) |
https://ClinicalTrials.gov/show/NCT00152906 |
Active, not recruiting |
University Health Network, Toronto |
2016-07-31 |
| NCT00149396 |
Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver |
https://ClinicalTrials.gov/show/NCT00149396 |
Completed |
MediGene |
2008-10-31 |
| NCT00143403 |
Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00143403 |
Completed |
Pfizer |
2008-02-29 |
| NCT00128596 |
Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00128596 |
Completed |
University of Pittsburgh |
2005-12-31 |
| NCT00122876 |
Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) |
https://ClinicalTrials.gov/show/NCT00122876 |
Completed |
Light Sciences LLC |
NA |
| NCT00109954 |
Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00109954 |
Completed |
University of Pittsburgh |
2005-12-31 |
| NCT00107536 |
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00107536 |
Completed |
National Cancer Institute (NCI) |
2009-05-31 |
| NCT00101036 |
Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00101036 |
Completed |
National Cancer Institute (NCI) |
2009-01-31 |
| NCT00096083 |
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer |
https://ClinicalTrials.gov/show/NCT00096083 |
Completed |
Delcath Systems Inc. |
2012-08-31 |
| NCT00095992 |
SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT00095992 |
Completed |
Canadian Cancer Trials Group |
2006-09-26 |
| NCT00094003 |
Study of NS-9 in Patients With Liver Metastases |
https://ClinicalTrials.gov/show/NCT00094003 |
Completed |
NS Pharma, Inc. |
NA |
| NCT00093444 |
Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors |
https://ClinicalTrials.gov/show/NCT00093444 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00004136 |
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT00004136 |
Completed |
M.D. Anderson Cancer Center |
2006-01-25 |
| NCT00002655 |
Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases |
https://ClinicalTrials.gov/show/NCT00002655 |
Completed |
University of Colorado, Denver |
1999-09-30 |
| NCT00003424 |
Tamoxifen in Treating Patients With Primary Liver Cancer |
https://ClinicalTrials.gov/show/NCT00003424 |
Completed |
National Cancer Institute (NCI) |
2000-06-30 |
| NCT00003557 |
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00003557 |
Completed |
University of Chicago |
2000-06-30 |
| NCT00087282 |
Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT00087282 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00083785 |
Study of the Litxâ„¢ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases |
https://ClinicalTrials.gov/show/NCT00083785 |
Completed |
Light Sciences LLC |
NA |
| NCT00083226 |
Doxorubicin and Bortezomib in Treating Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT00083226 |
Completed |
National Cancer Institute (NCI) |
2011-02-28 |
| NCT00003427 |
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00003427 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-04-30 |
| NCT00081848 |
Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors |
https://ClinicalTrials.gov/show/NCT00081848 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-08-23 |
| NCT00004108 |
DX-8951f in Treating Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT00004108 |
Completed |
Daiichi Sankyo, Inc. |
2005-04-30 |
| NCT00019474 |
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer |
https://ClinicalTrials.gov/show/NCT00019474 |
Completed |
Montefiore Medical Center |
2000-08-31 |
| NCT00081094 |
Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer |
https://ClinicalTrials.gov/show/NCT00081094 |
Completed |
Washington University School of Medicine |
2005-06-30 |
| NCT00007813 |
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors |
https://ClinicalTrials.gov/show/NCT00007813 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-02-01 |
| NCT00004248 |
Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00004248 |
Completed |
Roswell Park Cancer Institute |
2000-06-30 |
| NCT00077441 |
Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) |
https://ClinicalTrials.gov/show/NCT00077441 |
Completed |
National Cancer Institute (NCI) |
2006-06-30 |
| NCT00077142 |
TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) |
https://ClinicalTrials.gov/show/NCT00077142 |
Completed |
M.D. Anderson Cancer Center |
2005-07-31 |
| NCT00076609 |
Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00076609 |
Completed |
PhytoCeutica |
NA |
| NCT00009893 |
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00009893 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-01-31 |
| NCT00073905 |
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00073905 |
Completed |
Swiss Group for Clinical Cancer Research |
2006-06-30 |
| NCT00071994 |
Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) |
https://ClinicalTrials.gov/show/NCT00071994 |
Completed |
National Cancer Institute (NCI) |
2005-05-31 |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00003907 |
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver |
https://ClinicalTrials.gov/show/NCT00003907 |
Completed |
Eastern Cooperative Oncology Group |
2011-05-31 |
| NCT00005629 |
Vaccine Therapy in Treating Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT00005629 |
Completed |
Jonsson Comprehensive Cancer Center |
2002-05-31 |
| NCT00068068 |
Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases |
https://ClinicalTrials.gov/show/NCT00068068 |
Completed |
Light Sciences LLC |
NA |
| NCT00003912 |
Chemotherapy in Treating Children With Liver Cancer |
https://ClinicalTrials.gov/show/NCT00003912 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00033462 |
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00033462 |
Completed |
National Cancer Institute (NCI) |
2006-11-30 |
| NCT00059865 |
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00059865 |
Completed |
Alliance for Clinical Trials in Oncology |
2007-02-28 |
| NCT00058487 |
Epirubicin and Thalidomide in Treating Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT00058487 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00057980 |
Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00057980 |
Completed |
Northwestern University |
2007-02-28 |
| NCT00055692 |
Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT00055692 |
Completed |
National Cancer Institute (NCI) |
2008-01-31 |
| NCT00054262 |
T900607 in Treating Patients With Unresectable Liver Cancer |
https://ClinicalTrials.gov/show/NCT00054262 |
Completed |
National Cancer Institute (NCI) |
2004-03-31 |
| NCT00041275 |
Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00041275 |
Completed |
National Cancer Institute (NCI) |
2007-06-30 |
| NCT00052364 |
Oxaliplatin in Treating Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT00052364 |
Completed |
National Cancer Institute (NCI) |
2006-01-31 |
| NCT00049322 |
Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery |
https://ClinicalTrials.gov/show/NCT00049322 |
Completed |
Jonsson Comprehensive Cancer Center |
2012-02-29 |
| NCT00047346 |
Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction |
https://ClinicalTrials.gov/show/NCT00047346 |
Completed |
National Cancer Institute (NCI) |
2005-12-31 |
| NCT00047229 |
Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) |
https://ClinicalTrials.gov/show/NCT00047229 |
Completed |
University Health Network, Toronto |
2009-01-31 |
| NCT00040898 |
Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed |
https://ClinicalTrials.gov/show/NCT00040898 |
Completed |
Memorial Sloan Kettering Cancer Center |
2006-01-31 |
| NCT00036959 |
ABT-751 in Treating Young Patients With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00036959 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-02-28 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00030498 |
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction |
https://ClinicalTrials.gov/show/NCT00030498 |
Completed |
National Cancer Institute (NCI) |
2007-07-31 |
| NCT00030108 |
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven’t Responded to Therapy |
https://ClinicalTrials.gov/show/NCT00030108 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-03-31 |
| NCT00030082 |
Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer |
https://ClinicalTrials.gov/show/NCT00030082 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00028496 |
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00028496 |
Completed |
National Cancer Institute (NCI) |
2005-11-30 |
| NCT00027534 |
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00027534 |
Completed |
Duke University |
2007-10-31 |
| NCT00024258 |
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors |
https://ClinicalTrials.gov/show/NCT00024258 |
Completed |
Memorial Sloan Kettering Cancer Center |
2009-05-31 |
| NCT00022334 |
Vaccine Therapy in Treating Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT00022334 |
Completed |
Jonsson Comprehensive Cancer Center |
2004-12-31 |
| NCT00021047 |
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor |
https://ClinicalTrials.gov/show/NCT00021047 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00020150 |
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00020150 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019786 |
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases |
https://ClinicalTrials.gov/show/NCT00019786 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00019513 |
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00019513 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00019331 |
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT00019331 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00012324 |
Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer |
https://ClinicalTrials.gov/show/NCT00012324 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00006016 |
Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00006016 |
Completed |
National Cancer Institute (NCI) |
2005-04-30 |
| NCT00006010 |
Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer |
https://ClinicalTrials.gov/show/NCT00006010 |
Completed |
Alliance for Clinical Trials in Oncology |
2004-05-31 |
| NCT00006006 |
Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed |
https://ClinicalTrials.gov/show/NCT00006006 |
Completed |
National Cancer Institute (NCI) |
2005-03-31 |
| NCT00003994 |
Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT00003994 |
Completed |
Children’s Oncology Group |
2007-10-31 |
| NCT00002608 |
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00002608 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00002515 |
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer |
https://ClinicalTrials.gov/show/NCT00002515 |
Completed |
Memorial Sloan Kettering Cancer Center |
2005-04-30 |
| NCT00001587 |
A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver |
https://ClinicalTrials.gov/show/NCT00001587 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00041808 |
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver |
https://ClinicalTrials.gov/show/NCT00041808 |
Completed |
FeRx |
NA |
| NCT00717756 |
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial |
https://ClinicalTrials.gov/show/NCT00717756 |
Completed |
Brown University |
2013-12-31 |
| NCT00639509 |
IMC-A12 in Treating Patients With Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT00639509 |
Completed |
National Cancer Institute (NCI) |
2011-02-28 |
| NCT00608361 |
Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00608361 |
Completed |
National Cancer Institute (NCI) |
2014-08-31 |
| NCT00001576 |
A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver |
https://ClinicalTrials.gov/show/NCT00001576 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |